UK market leading electronic cigarette and e-liquid manufacturer Intellicig held a one day conference for the company’s nationwide team of 20 Retail Customer Managers at its UMIC Laboratory continued…
Part of the UMIC team, Dr Martino Picardo and Tony Walker, recently visited the Bulgarian town of Burgas on an international collaboration exchange on incubation. It is the capital of Burgas continued…
UMIC is planning to create an incubator focused on the growing low carbon and environmental sector. This will drive forward the Manchester Low Carbon Incubator Centre (LCIC) idea into a programme continued…
Nanoco Group, the AIM-listed developer of quantum dots and other nanomaterials, has a secured a “milestone” payment of $600,000 from an unnamed Japanese electronics company.
The continued…
UMIC, the facilities management and business support service provider for the University of Manchester, was delighted to welcome Vince Cable, the Secretary of State for Business, Innovation and continued…
UMIC is pleased to announce that in partnership with Ikon Informatix, we will be hosting a Bioscience Suppliers Fair at the Core Technology Facility on 11 November 2010.
This event will offer continued…
UMIC, the facilities management and business support service provider for the University of Manchester, in partnership with pro•manchester successfully hosted an Investment for continued…
UMIC are delighted to announce the launch of the Manchester MicroMasterclass, a series of events designed to help you grow your business successfully. Join us for bite-sized business seminars continued…
Epistem plc (LSE: EHP), the UK biotechnology company, announced today that its Contract Research Services division has entered into an agreement with the Veritas Corporation to exclusively market continued…
Gentronix Ltd, the Manchester based Genotoxicity and Predictive Toxicology Company announces that it has recently successfully completed a £610k Rights Issue, fully underwritten by its two continued…
Renovo Group, the developer of anti-scarring and scar prevention treatments, has announced further progress in the trials of its flagship Juvista drug.
The Manchester company (based in the Core continued…
Manchester based hi-tech investment specialists, MTI Partners, has announced a UPF (the UMIP Premier Fund) investment, in University of Manchester med-tech spin-out BiOxyDyn.
BiOxyDyn, which is continued…
